Impact of acute and chronic stressor experiences on heart atrial and brain natriuretic peptides in response to a subsequent stressor

Hormones and Behavior

Volumn 58, Issue 5, 2010, Pages 907-916

  Wann, Boubacar Pasto ^a   Audet, Marie Claude ^a   Anisman, Hymie ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

Acute stressor; Atrial; Atrial and brain natriuretic peptides; Chronic stressor; Desensitization; Locus coeruleus; Norepinephrine; Sensitization; Ventricle

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CORTICOSTERONE; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; NORADRENALIN;

ACUTE STRESS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN REGION; BRAIN VENTRICLE; CARDIOVASCULAR FUNCTION; CHRONIC STRESS; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; HEART FUNCTION; LOCUS CERULEUS; MALE; MENTAL STRESS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADAPTATION, PSYCHOLOGICAL; ANIMALS; ATRIAL NATRIURETIC FACTOR; BRAIN; CORTICOSTERONE; CYTOKINES; MALE; METHOXYHYDROXYPHENYLGLYCOL; MICE; MYOCARDIUM; NATRIURETIC PEPTIDE, BRAIN; NOREPINEPHRINE; RECURRENCE; STRESS, PSYCHOLOGICAL; TIME FACTORS;

EID: 78349306663     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2010.09.001     Document Type: Article

References (46)

1. Anderson J.L., Krause-Steinrauf H., Goldman S., Clemson B.S., Domanski M.J., Hager W.D., Murray D.R., Mann D.L., Massie B.M., McNamara D.M., Oren R., Rogers W.J. Failure of benefit and early hazard of bucindolol for Class IV heart failure. J. Card. Fail. 2003, 9:266-277.
2. Anisman H., Merali Z. Cytokines, stress and depressive illness: brain-immune interactions. Ann. Med. 2003, 35:2-11.
3. Anisman H., Hayley S., Merali Z. Cytokines and stress: sensitization and cross-sensitization. Brain Behav. Immun. 2003, 17:86-93.
4. Anisman H., Prakash P., Merali Z., Poulter M.O. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice. Behav. Brain Res. 2007, 181:180-190.
5. Anisman H., Merali Z., Hayley S. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders. Prog. Neurobiol. 2008, 85:1-74.
6. Aoshima H., Yokoyama T., Tanizaki J., Izu H., Yamada M. The sugar specificity of Na+/glucose cotransporter from rat jejunum. Biosci. Biotechnol. Biochem. 1997, 61:979-983.
7. Armario A., Escorihuela R.M., Nadal R. Long-term neuroendocrine and behavioural effects of a single exposure to stress in adult animals. Neurosci. Biobehav. Rev. 2008, 32:1121-1135.
8. Audet M.C., Anisman H. Neuroendocrine and neurochemical impact of aggressive social interactions in submissive and dominant mice: implications for stress-related disorders. Int. J. Neuropsychopharmacol. 2010, 13:361-372.
9. Blumenthal S.B., Kiemer A.K., Tiegs G., Seyfried S., Holtje M., Brandt B., Holtje H.D., Zahler S., Vollmar A.M. Metalloporphyrins inactivate caspase-3 and -8. FASEB J. 2005, 19:1272-1279.
10. Bozkurt B., Kribbs S.B., Clubb F.J., Michael L.H., Didenko V.V., Hornsby P.J., Seta Y., Oral H., Spinale F.G., Mann D.L. Pathophysiologically relevant concentrations of tumor necrosis factor-alpha promote progressive left ventricular dysfunction and remodeling in rats. Circulation 1998, 97:1382-1391.
11. Brown A.D., Barton D.A., Lambert G.W. Cardiovascular abnormalities in patients with major depressive disorder: autonomic mechanisms and implications for treatment. CNS Drugs 2009, 23:583-602.
12. Buwalda B., de Boer S.F., Schmidt E.D., Felszeghy K., Nyakas C., Sgoifo A., Van der Vegt B.J., Tilders F.J., Bohus B., Koolhaas J.M. Long-lasting deficient dexamethasone suppression of hypothalamic-pituitary-adrenocortical activation following peripheral CRF challenge in socially defeated rats. J. Neuroendocrinol 1999, 11:513-520.
13. Campbell S., MacQueen G. The role of the hippocampus in the pathophysiology of major depression. J. Psychiatry Neurosci. 2004, 29:417-426.
14. Carpeggiani C., L'Abbate A., Landi P., Michelassi C., Raciti M., Macerata A., Emdin M. Early assessment of heart rate variability is predictive of in-hospital death and major complications after acute myocardial infarction. Int. J. Cardiol. 2004, 96:361-368.
15. Dalack G., Roose S. Perspectives on the relationship between cardiovascular disease and affective disorder. J. Clin. Psychiatry 1990, 51:4-11.
16. Emdin M., Passino C., Prontera C., Iervasi A., Ripoli A., Masini S., Zucchelli G.C., Clerico A. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin. Chem. Lab. Med. 2004, 42:627-636.
17. Franklin K.B.J., Paxinos G. A Stereotaxic Atlas of the Mouse Brain 1997, Academic Pres, San Diego, California.
18. Frasure-Smith N., Lespérance F., Irwin M.R., Talajic M., Pollock B.G. The relationships among heart rate variability, inflammatory markers and depression in coronary heart disease patients. Brain Behav. Immun. 2009, 23:1140-1147.
19. Goetze J.P., Videbaek R., Boesgaard S., Aldershvile J., Rehfeld J.F., Carlsen J. Pro-brain natriuretic peptide as marker of cardiovascular or pulmonary causes of dyspnea in patients with terminal parenchymal lung disease. J. Heart Lung Transplant. 2004, 23:80-87.
20. Grabie N., Hsieh D.T., Buono C., Westrich J.R., Allen J.A., Pang H., Stavrakis G., Lichtman A.H. Neutrophils sustain pathogenic CD8+ T cell responses in the heart. Am. J. Pathol. 2003, 163:2413-2420.
21. Guo Z.L., Li P., Longhurst J.C. Central pathways in the pons and midbrain involved in cardiac sympathoexcitatory reflexes in cats. Neuroscience 2002, 113:435-447.
22. Gutkowska J., Paquette A., Wang D., Lavoie J.M., Jankowski M. Effect of exercise training on cardiac oxytocin and natriuretic peptide systems in ovariectomized rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R267-R275.
23. Hatton D.C., Brooks V., Qi Y., McCarron D.A. Cardiovascular response to stress: baroreflex resetting and hemodynamics. Am. J. Physiol. 1997, 272:R1588-R1594.
24. Hayley S., Brebner K., Lacosta S., Merali Z., Anisman H. Sensitization to the effects of tumor necrosis factor-alpha: neuroendocrine, central monoamine, and behavioral variations. J. Neurosci. 1999, 19:5654-5665.
25. Hofmann U., Heuer S., Meder K., Boehler J., Lange V., Quaschning T., Ertl G., Bonz A. The proinflammatory cytokines TNF-alpha and IL-1 beta impair economy of contraction in human myocardium. Cytokine 2007, 39:157-162.
26. Ichihara C., Kawakami N., Yasuno S., Hino A., Fujikawa K., Kobayashi A., Ochi M., Gotoh H., Kugimiya T. Characterization of interface of Al-Ni/a-Si for thin film transistor using high-resolution Rutherford backscattering spectrometry. Micron 2009, 40:66-69.
27. Iyer V., Edelman E., Lilly L. Pathophysiology of heart disease: a collaborative project of medical students and faculty. Pathophysiology of Heart Disease 2006, 473. Lippincott Williams & Wilkins. Lilly (Ed.).
28. Lesperance F., Frasure-Smith N. Depression in patients with cardiac disease: a practical review. J. Psychosom. Res. 2000, 48:379-391.
29. Libetta C., Sepe V., Zucchi M., Pisacco P., Cosmai L., Meloni F., Campana C., Rampino T., Monti C., Tavazzi L., Dal Canton A. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines. Nephrol. Dial. Transplant. 2007, 22:2013-2019.
30. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
31. Lynn S.E., Prince L.E., Phillips M.M. A single exposure to an acute stressor has lasting consequences for the hypothalamo-pituitary-adrenal response to stress in free-living birds. Gen. Comp. Endocrinol. 2010, 165:337-344.
32. McEwen B.S. Protective and damaging effects of stress mediators: central role of the brain. Dialogues Clin. Neurosci. 2006, 8:367-381.
33. McGrath M.F., de Bold A.J. Determinants of natriuretic peptide gene expression. Peptides 2005, 26:933-943.
34. Mekontso-Dessap A., Brochard L. BNP in intensive care unit: what prospect for the patient under mechanical ventilation. Réanimation. 2006, 15:48-54.
35. Patel K.P., Zhang K. Neurohumoral activation in heart failure: role of paraventricular nucleus. Clin. Exp. Pharmacol. Physiol. 1996, 23:722-726.
36. Piechota M., Banach M., Jacon A., Rysz J. Natriuretic peptides in cardiovascular diseases. Cell. Mol. Biol. Lett. 2008, 13:155-181.
37. Porter J.P. Contribution of central ANG II to acute stress-induced changes in baroreflex function in young rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000, 279:R1386-R1391.
38. Roy S.G., De P., Mukherjee D., Chander V., Konar A., Bandyopadhyay D., Bandyopadhyay A. Excess of glucocorticoid induces cardiac dysfunction via activating angiotensin II pathway. Cell. Physiol. Biochem. 2009, 24:1-10.
39. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
40. Tannenbaum B., Tannenbaum G.S., Sudom K., Anisman H. Neurochemical and behavioral alterations elicited by a chronic intermittent stressor regimen: implications for allostatic load. Brain Res. 2002, 953:82-92.
41. Tavener S.A., Kubes P. Cellular and molecular mechanisms underlying LPS-associated myocyte impairment. Am. J. Physiol. Heart Circ. Physiol. 2006, 290:H800-H806.
42. Tilders F.J.H., Schmidt E.D. Cross-sensitization between immune and non-immune stressors. A role in the etiology of depression?. Adv. Exp. Med. Biol. 1999, 461:179-197.
43. Tilders F.J.H., Schmidt E.D.De., Goeij D.C.E. Phenotypic plasticity of CRF neurons during stress. Ann. N.Y. Acad. Sci. 1993, 697:39-52.
44. Tse M.Y., Watson J.D., Sarda I.R., Flynn T.G., Pang S.C. Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice. Mol. Cell. Biochem. 2001, 219:99-105.
45. Ueyama T., Senba E., Kasamatsu K., Hano T., Yamamoto K., Nishio I., Tsuruo Y., Yoshida K. Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack. J. Cardiovasc. Pharmacol. 2003, 41(Suppl 1):S115-S118.
46. Wann B.P., Audet M.C., Gibb J., Anisman H. Anhedonia and altered cardiac atrial natriuretic peptide following chronic stressor and endotoxin treatment in mice. Psychoneuroendocrinology 2010, 35:233-240.